Cell cycle and apoptosis
暂无分享,去创建一个
K. Vermeulen | Z. Berneman | D. V. van Bockstaele | Katrien Vermeulen | Zwi N. Berneman | Dirk R. Van Bockstaele
[1] M. Blagosklonny. Unwinding the loop of Bcl-2 phosphorylation , 2001, Leukemia.
[2] M. Muda,et al. Bcl-2 Undergoes Phosphorylation by c-Jun N-terminal Kinase/Stress-activated Protein Kinases in the Presence of the Constitutively Active GTP-binding Protein Rac1* , 1997, The Journal of Biological Chemistry.
[3] Y. Furukawa,et al. Phosphorylation of Bcl-2 Protein by CDC2 Kinase during G2/M Phases and Its Role in Cell Cycle Regulation* , 2000, The Journal of Biological Chemistry.
[4] A. Berns,et al. A link between cell cycle and cell death: Bax and Bcl‐2 modulate Cdk2 activation during thymocyte apoptosis , 1998, The EMBO journal.
[5] R. Eisenman,et al. The Myc/Max/Mad network and the transcriptional control of cell behavior. , 2000, Annual review of cell and developmental biology.
[6] G. Prendergast,et al. c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. , 1995, Oncogene.
[7] Vijay R Baichwal,et al. Apoptosis: Activate NF-κB or die? , 1997, Current Biology.
[8] G. Evan,et al. Cell cycle: On target with Myc , 1996, Current Biology.
[9] Dirk Bohmann,et al. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis , 1999, Oncogene.
[10] J. Sedivy,et al. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[11] T. McDonnell,et al. Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis. , 1995, Oncogene.
[12] G. Salvesen,et al. The Regulation of Anoikis: MEKK-1 Activation Requires Cleavage by Caspases , 1997, Cell.
[13] J. Cleveland,et al. Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis , 1994, Molecular and cellular biology.
[14] Eric Wickstrom,et al. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1 , 1987, Nature.
[15] K. Vermeulen,et al. Plant cytokinin analogues with inhibitory activity on cyclin-dependent kinases exert their antiproliferative effect through induction of apoptosis initiated by the mitochondrial pathway: determination by a multiparametric flow cytometric analysis. , 2002, Experimental hematology.
[16] Marty W. Mayo,et al. TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.
[17] J. McCubrey,et al. Kinases: positive and negative regulators of apoptosis , 2000, Leukemia.
[18] M. Grafe,et al. Transcriptional Regulation of the BCL-X Gene by NF-κB Is an Element of Hypoxic Responses in the Rat Brain , 2004, Neurochemical Research.
[19] David S. Park,et al. Inhibitors of Cyclin-dependent Kinases Promote Survival of Post-mitotic Neuronally Differentiated PC12 Cells and Sympathetic Neurons (*) , 1996, The Journal of Biological Chemistry.
[20] E. Sausville,et al. Flavopiridol induces apoptosis of normal lymphoid cells, causes immunosuppression, and has potent antitumor activity In vivo against human leukemia and lymphoma xenografts. , 1998, Blood.
[21] C. Blattner,et al. Transcription Factor E2F-1 Is Upregulated in Response to DNA Damage in a Manner Analogous to That of p53 , 1999, Molecular and Cellular Biology.
[22] D. Green,et al. Withdrawal of Survival Factors Results in Activation of the JNK Pathway in Neuronal Cells Leading to Fas Ligand Induction and Cell Death , 1999, Molecular and Cellular Biology.
[23] R. Schlegel,et al. Suppression of Apoptosis by Dominant Negative Mutants of Cyclin-dependent Protein Kinases (*) , 1996, The Journal of Biological Chemistry.
[24] C. Steer,et al. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells. , 1996, Oncogene.
[25] D. Beach,et al. Cdc25 cell-cycle phosphatase as a target of c-myc , 1996, Nature.
[26] J. Cleveland,et al. The role of ornithine decarboxylase in c-Myc-induced apoptosis. , 1995, Current topics in microbiology and immunology.
[27] G. Evan,et al. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB , 1997, Nature.
[28] J. Myklebust,et al. Activation of the CAMP signaling pathway increases apoptosis in human B‐precursor cells and is associated with downregulation of Mcl‐1 expression , 1998, Journal of cellular physiology.
[29] C. Widmann,et al. Potentiation of apoptosis by low dose stress stimuli in cells expressing activated MEK kinase 1 , 1997, Oncogene.
[30] D. Bar-Sagi,et al. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. , 2000, Science.
[31] Kazuhito Yamamoto,et al. BCL-2 Is Phosphorylated and Inactivated by an ASK1/Jun N-Terminal Protein Kinase Pathway Normally Activated at G2/M , 1999, Molecular and Cellular Biology.
[32] G. Linette,et al. Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[33] R. Craig,et al. Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells. , 1994, Cancer research.
[34] G. Evan,et al. Proliferation, cell cycle and apoptosis in cancer , 2001, Nature.
[35] M. Marshall. Interactions between Ras and Raf: Key regulatory proteins in cellular transformation , 1995, Molecular reproduction and development.
[36] T. Curran,et al. Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation. Characterization of the phosphorylation of c-myc and c-jun proteins by an epidermal growth factor receptor threonine 669 protein kinase. , 1991, The Journal of biological chemistry.
[37] A. Levine. p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.
[38] E. Thompson,et al. The many roles of c-Myc in apoptosis. , 1998, Annual review of physiology.
[39] U. Rapp,et al. Isotype-specific functions of Raf kinases. , 1999, Experimental cell research.
[40] Stephen S. Gisselbrecht,et al. Activation of cyclin A-dependent protein kinases during apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[41] H. Hermeking,et al. Mediation of c-Myc-induced apoptosis by p53. , 1994, Science.
[42] M. Kasten,et al. pRb and the Cdks in apoptosis and the cell cycle , 1998, Cell Death and Differentiation.
[43] G. Kroemer,et al. Apoptosis and cell cycle: distinct checkpoints with overlapping upstream control. , 2000, Pathologie-biologie.
[44] J. Romashkova,et al. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. , 1999, Nature.
[45] NFκB Mediates Apoptosis through Transcriptional Activation of Fas (CD95) in Adenoviral Hepatitis* , 2000, The Journal of Biological Chemistry.
[46] M. Cole,et al. The c-Myc Transactivation Domain Is a Direct Modulator of Apoptotic versus Proliferative Signals , 2000, Molecular and Cellular Biology.
[47] A. Hakem,et al. The Cyclin-dependent Kinase Cdk2 Regulates Thymocyte Apoptosis , 1999, The Journal of experimental medicine.
[48] Chi V. Dang,et al. c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism , 1999, Molecular and Cellular Biology.
[49] F. Alt,et al. Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. , 2001, Immunity.
[50] T. Hofmann,et al. The pro- or anti-apoptotic function of NF-kappaB is determined by the nature of the apoptotic stimulus. , 2000, European journal of biochemistry.
[51] V R Baichwal,et al. Activate NF-kappa B or die? , 1997, Current biology : CB.
[52] T. Jacks,et al. Loss of Rb activates both p53‐dependent and independent cell death pathways in the developing mouse nervous system. , 1996, The EMBO journal.
[53] D. Green,et al. Apoptotic cell death induced by c-myc is inhibited by bcl-2 , 1992, Nature.
[54] G. Evan,et al. Cooperative interaction between c-myc and bcl-2 proto-oncogenes , 1992, Nature.
[55] Y. H. Kim,et al. Up-regulation of c-myc induces the gene expression of the murine homologues of p34cdc2 and cyclin-dependent kinase-2 in T lymphocytes. , 1994, Journal of immunology.
[56] Sam W. Lee,et al. p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53 , 1999, Oncogene.
[57] R. Eisenman,et al. c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells , 1985, Nature.
[58] J. Cidlowski,et al. Cell cycle regulation and apoptosis. , 1998, Annual review of physiology.
[59] L. Rubin,et al. The molecular mechanisms of neuronal apoptosis , 1994, Current Opinion in Neurobiology.
[60] M. Gorospe,et al. p27Kip1 overexpression causes apoptotic death of mammalian cells , 1997, Oncogene.
[61] Claus Scheidereit,et al. NF-κB Function in Growth Control: Regulation of Cyclin D1 Expression and G0/G1-to-S-Phase Transition , 1999, Molecular and Cellular Biology.
[62] S. Leach,et al. Mitotic Phosphorylation of Bcl-2 during Normal Cell Cycle Progression and Taxol-induced Growth Arrest* , 1998, The Journal of Biological Chemistry.
[63] M. Kasten,et al. Cell cycle and apoptosis. , 2000, Neoplasia.
[64] W. Kolch,et al. Mechanism of inhibition of Raf-1 by protein kinase A , 1994, Molecular and cellular biology.
[65] D. Andrews,et al. Myc Potentiates Apoptosis by Stimulating Bax Activity at the Mitochondria , 2001, Molecular and Cellular Biology.
[66] Y. Lazebnik,et al. Primary cells suppress oncogene-dependent apoptosis , 2000, Nature Cell Biology.
[67] M. Grever,et al. Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53. , 1998, Blood.
[68] C. Croce,et al. Inactivation of Bcl-2 by phosphorylation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[69] K. Helin,et al. Apaf-1 is a transcriptional target for E2F and p53 , 2001, Nature Cell Biology.
[70] D. Bergstrom,et al. Participation of cyclin A in Myc-induced apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[71] L. Penn,et al. C-MYC: evidence for multiple regulatory functions. , 1990, Seminars in cancer biology.
[72] K. Arai,et al. Regulation of Bcl-2 expression by oncogenic Ras protein in hematopoietic cells. , 1995, Oncogene.
[73] J. Tyson,et al. Regulation of the eukaryotic cell cycle: molecular antagonism, hysteresis, and irreversible transitions. , 2001, Journal of theoretical biology.
[74] W. Ansorge,et al. Induction of cyclin E–cdk2 kinase activity, E2F‐dependent transcription and cell growth by Myc are genetically separable events , 2000, The EMBO journal.
[75] T. Yagi,et al. Mutated p21WAF1/CIP1/SDI1 lacking CDK-inhibitory activity fails to prevent apoptosis in human colorectal carcinoma cells , 1998, Oncogene.
[76] E. Kandel,et al. Induction of Cell Cycle Progression and Acceleration of Apoptosis Are Two Separable Functions of c-Myc: Transrepression Correlates with Acceleration of Apoptosis , 2000, Molecular and Cellular Biology.
[77] A. Adjei,et al. Blocking oncogenic Ras signaling for cancer therapy. , 2001, Journal of the National Cancer Institute.
[78] J. Romashkova,et al. NF-κB is a target of AKT in anti-apoptotic PDGF signalling , 1999, Nature.
[79] John Calvin Reed,et al. Regulation of cell death protease caspase-9 by phosphorylation. , 1998, Science.
[80] R. Eisenman,et al. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. , 1991, Science.
[81] D. Baltimore,et al. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. , 1996, Science.
[82] E. Prochownik,et al. Genetic dissection of c-myc apoptotic pathways , 2000, Oncogene.
[83] M. Groudine,et al. Control of c-myc regulation in normal and neoplastic cells. , 1991, Advances in cancer research.
[84] L. Penn,et al. The myc oncogene: MarvelouslY Complex. , 2002, Advances in cancer research.
[85] M L Agarwal,et al. The p53 Network* , 1998, The Journal of Biological Chemistry.
[86] David Baltimore,et al. An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.
[87] J L Cleveland,et al. E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis , 1995, Molecular and cellular biology.
[88] S. Cory,et al. The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.
[89] Susan S. Taylor,et al. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. , 1999, Molecular cell.
[90] Yufang Shi,et al. Fungal metabolite FR901228 inhibits c-Myc and Fas ligand expression , 1998, Oncogene.
[91] X. F. Zhang,et al. Raf meets Ras: completing the framework of a signal transduction pathway. , 1994, Trends in biochemical sciences.
[92] L. M. Facchini,et al. The molecular role of Myc in growth and transformation: recent discoveries lead to new insights , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[93] R. DePinho,et al. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens , 1994, Nature.
[94] A. Asai,et al. Expression level of Bcl-2 determines anti- or proapoptotic function. , 1999, Cancer research.
[95] N. Holbrook,et al. Protective Role for c-Jun in the Cellular Response to DNA Damage* , 2001, The Journal of Biological Chemistry.
[96] R M Chau,et al. [Cell cycle and apoptosis]. , 1996, Sheng li ke xue jin zhan [Progress in physiology].
[97] E. Shaulian,et al. Induction of apoptosis in HeLa cells by trans-activation-deficient p53. , 1995, Genes & development.
[98] John Calvin Reed,et al. Bax is a transcriptional target and mediator of c-myc-induced apoptosis. , 2000, Cancer research.
[99] J. Cheville,et al. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. , 1999, The American journal of pathology.
[100] H. Petrie,et al. Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death , 1996, The Journal of experimental medicine.
[101] J. Frost,et al. c-Myc cooperates with activated Ras to induce the cdc2 promoter , 1994, Molecular and cellular biology.
[102] V. Rotter,et al. c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[103] Ronit Vogt Sionov,et al. The cellular response to p53: the decision between life and death , 1999, Oncogene.
[104] K. Vermeulen,et al. Antiproliferative effect of plant cytokinin analogues with an inhibitory activity on cyclin-dependent kinases , 2002, Leukemia.
[105] B. Lutterbach,et al. Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis , 1994, Molecular and cellular biology.
[106] S. Shankland,et al. Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1). , 1999, The Journal of clinical investigation.